We don’t ring-fence set amounts of money to be spent on particular cancer types – the amount we spend varies from year to year as new research projects start and finish.
Watch this video to find out how we ensure we only fund the best science that stands the best chance of making a difference for people affected by cancer.
What we spent on different cancer types in 2016/17
We spent £386 million on life-saving research carried out in 2016/17, including £112 million into the biology of cancer that underpins the rest of our research. We also set aside money for future work on long-term projects that are running over several years. The total amount we put towards research in 2016/17 was £432 million.
We’re working to prevent cancer, diagnose it earlier, develop new treatments and optimise existing treatments to make them more effective. Our 2016/17 spend on research includes £38 million on clinical trials, £37 million on research into new drugs, and £17 million on research into possible causes of cancer, helping people to reduce their risk.
We always aim to fund the best quality research with the greatest potential to bring benefits to people affected by all types of cancer. Accelerating progress against hard-to-treat cancers – brain tumours and lung, pancreatic and oesophageal cancers – is a priority for Cancer Research UK. When we launched our research strategy in 2014, increasing the amount we invest in this area was a vital goal. Since then, we’ve increased our funding, this year spending a total of £85 million – 13% more than last year. We’ve also supported the research community in these cancers to make sure there are more high-quality projects on these cancers to fund.